SciELO - Scientific Electronic Library Online

 
vol.18 número4Embolismo por cristales de colesterol: A propósito de un casoIntoxicación por paraquat: presentación de dos casos y revisión de la literatura índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

Compartir


Anales de Medicina Interna

versión impresa ISSN 0212-7199

Resumen

PANTOJA ZARZA, L.; PANIAGUA DE LA RIVA, J.; MEGIDO LAHERA, M.  y  ORTIZ DE SARACHO, J.. Primary systemic amyloidosis presenting as polymialgia  rheumatica and giant cell arteritis. An. Med. Interna (Madrid) [online]. 2001, vol.18, n.4, pp.45-49. ISSN 0212-7199.

Primary systemic amyloidosis or AL-amyloidosis is an uncommon disease characterized by the accumulation in vital organs of a fibrillar protein consisting of monoclonal light chains. It is a plasma-cell dyscrasia related to multiple myeloma where clonal plasma cells in the bone marrow produce immunoglobulins that are amyloidogenic. A monoclonal component is present in the serum or urine of 90% of patients. The presentation of most patients with AL amyloidosis is usually related to congestive heart failure, nephrotic syndrome o peripheral neuropathy, but there are unusual features suggesting giant cell arteritis (GCA) and polymyalgia rheumatic (PMR). Although in the majority of AL cases the plasma cells clone is small, the assumption is that the outcome of the disease is uniformly fatal (median survival 12-15 months) and treatment is analogous to those used in malignant proliferative disease. We describe a patient with AL amyloidosis who presented with manifestations of GCA and PMR, and we review the main characteristics of primary amyloidosis.

Palabras clave : Primary systemic amyloidosis; Giant cell artritis; Polymyalgia rheumatica.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons